Education
About Us
Working with TipRanks
Follow Us
Novolog (Pharm UP 1966) Ltd. (IL:NVLG)
:NVLG
NVLG Stock Chart & Stats
Day’s Range― - ―
52-Week Range131.70 - 196.00
Previous CloseN/A
Volume351.22K
Average Volume (3M)406.31K
Market Cap
690.19M
Enterprise Value907.65M
Total Cash (Recent Filing)111.22M
Total Debt (Recent Filing)191.08M
Price to Earnings (P/E)24.2
Beta0.77
Next Earnings
Nov 12, 2025EPS EstimateN/A
Last Dividend Ex-Date
Dec 02, 2024Dividend Yield5.83%
Share Statistics
EPS (TTM)0.90
Shares Outstanding510,874,760
10 Day Avg. Volume482,577
30 Day Avg. Volume406,313
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
155.00Price Target Upside16.28% Upside
Rating ConsensusHold
Number of Analyst Covering0
Novolog News
NVLG FAQ
What was Novolog (Pharm UP 1966) Ltd.’s price range in the past 12 months?
Novolog (Pharm UP 1966) Ltd. lowest stock price was 131.70 and its highest was 196.00 in the past 12 months.
What is Novolog (Pharm UP 1966) Ltd.’s market cap?
Novolog (Pharm UP 1966) Ltd.’s market cap is 690.19M.
When is Novolog (Pharm UP 1966) Ltd.’s upcoming earnings report date?
Novolog (Pharm UP 1966) Ltd.’s upcoming earnings report date is Nov 12, 2025 which is in 83 days.
How were Novolog (Pharm UP 1966) Ltd.’s earnings last quarter?
Novolog (Pharm UP 1966) Ltd. released its earnings results on Aug 19, 2025. The company reported 0.9 earnings per share for the quarter, beating the consensus estimate of N/A by 0.9.
Is Novolog (Pharm UP 1966) Ltd. overvalued?
According to Wall Street analysts Novolog (Pharm UP 1966) Ltd.’s price is currently Undervalued.
Does Novolog (Pharm UP 1966) Ltd. pay dividends?
Novolog (Pharm UP 1966) Ltd. pays a Quarterly dividend of 1.958 which represents an annual dividend yield of 5.83%. See more information on Novolog (Pharm UP 1966) Ltd. dividends here
What is Novolog (Pharm UP 1966) Ltd.’s EPS estimate?
Novolog (Pharm UP 1966) Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Novolog (Pharm UP 1966) Ltd. have?
Novolog (Pharm UP 1966) Ltd. has 510,874,760 shares outstanding.
What happened to Novolog (Pharm UP 1966) Ltd.’s price movement after its last earnings report?
Novolog (Pharm UP 1966) Ltd. reported an EPS of 0.9 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.675%.
Which hedge fund is a major shareholder of Novolog (Pharm UP 1966) Ltd.?
Currently, no hedge funds are holding shares in IL:NVLG
Company Description
Novolog (Pharm UP 1966) Ltd.
Novolog (NVLG) is a logistics and supply chain management company specializing in providing efficient and innovative solutions for the pharmaceutical and healthcare sectors. The company offers a range of services including warehousing, distribution, and transportation, ensuring that critical healthcare products are delivered safely and on time. Novolog is committed to leveraging technology and expertise to optimize supply chain operations for its clients, thereby enhancing the availability and accessibility of essential medical supplies.